Trial NCT04203901

View at ClinicalTrials.gov 
Org. Study IDs: CMN-001-1

Last trial update was posted on 2023-10-02

MeSH Interventions

Everolimus Ipilimumab Lenvatinib Nivolumab

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Advanced Renal Cell Carcinoma

Stopping Reasons

Strategic corporate decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID